The Coexistence of Hypertension and Dyslipidemia in a Cohort of Iraqi patients with essential Hypertension: Cross Sectional Study| Biomed Grid

Background: Hypertension and hyperlipidemia are among major risk factors for ischemic heart disease, the principal human killer worldwide. In addition, they form important components of the well-established metabolic syndrome. Generally speaking, dyslipidemia comprises abnormality in the level of triglyceride, HDL-cholesterol and LDL-cholesterol. The description of hypertension and dyslipidemia as a single entity under the title “dyslipidemic hypertension (DH)” has emerged in medical literatures since 1988; a suggestion was made at that time as being a genetic syndrome to explain the coexistence of dyslipidemia and essential hypertension in a subset of patients. Aim of the study: To estimate the prevalence rate of co-existence of dyslipidemia and hypertension in a cohort of Iraqi patients with essential hypertension. Patients and methods: The present cross-sectional study included 183 patients with essential hypertension who have sought medical advice for treating hypertension in Al-Diwaniyah Teaching hospital / Medicine consultation Unit. The study extended from January 2018 through January 2019. Variables included in the current study were age, gender, systolic and diastolic blood pressure, serum lipid profile, history of IHD and diabetes mellitus (DM) and family history of dyslipidemia. Results: High proportion of patients with essential hypertension have in addition dyslipidemia accounting for 106 out of 120 (approximately 88 %). There was significant association between coexistence of hypertension and dyslipidemia and gender or age of patients (P > 0.05); in addition, there was no significant association between other co morbidities such as IHD, diabetes mellitus and thyroid disorders and the coexistence of hypertension and dyslipidemia (P > 0.05). Conclusion: the prevalence rate of simultaneous occurrence of dyslipidemia and hypertension is common in our community and there should be a program to detect those patients because higher risk of morbidity and mortality in such patients